Search for: "Grant v. Bristol-Myers Squibb"
Results 41 - 60
of 140
Sorted by Relevance
|
Sort by Date
13 Feb 2013, 11:49 pm
For those interested, the Indian patent number is 213457 and the case details are: Bristol-Myers Squibb Company v. [read post]
15 Apr 2010, 4:27 am
(EPLAW) Prevacid (Lansoprazole) – US: Takeda files patent infringement complaint against Zydus following Para IV challenge (Patent Docs) Reyataz (Atazanavir) – US: Bristol-Myer Squibb, Novartis file patent infringement suit against Teva following Para IV challenge (Patent Docs) Treximet (Sumatriptan, Naproxen) – US: POZEN enters into settlement agreement with Teva regarding Para IV patent litigation (SmartBrief) Zerit (Stavudine) – US: Promote… [read post]
28 Oct 2007, 7:21 pm
Cir. 2007) In the early 1990s, Bristol-Myers Squibb developed and patented Megace, a liquid pharmaceutical composition of megestrol acetate indicated for the treatment of anorexia, cachexia, or an unexplained weight loss. [read post]
25 Apr 2010, 5:52 pm
Bristol-Myers Squibb Co. [read post]
25 Feb 2013, 2:39 pm
Bristol Myers Squibb Co., No. 2013 U.S. [read post]
16 Feb 2011, 12:04 am
It looks like they would also do away with all the problems of the “threshold” requirement introduced by Phillips v Mirabella (the nature of the problem is laid out at paragraphs 19 to 27 of Bristol-Myers Squibb v Faulding). [read post]
17 Feb 2017, 12:21 pm
Bristol-Myers Squibb Co. v. [read post]
6 May 2013, 4:33 pm
Thus, reciting Bristol-Myers Squibb Co. v Ben Venue Labs. [read post]
24 Jan 2007, 9:59 pm
It was also recently reported that Lek D.D., a subsidiary of Sandoz, filed a complaint for patent infringement against Bristol-Myers Squibb and Watson Pharmaceuticals relating to BMS's Pravachol (pravastatin sodium). [read post]
13 Feb 2015, 12:00 pm
That case alleged that AstraZeneca and Bristol-Myers Squibb paid disguised, undisclosed rebates, fees and grants to Medco for purchasing their drugs while inaccurately reporting pricing information to the government. [read post]
10 Dec 2010, 3:06 am
Inc., 2000 US Dist LEXIS 21316, *12-13 [2000]; Grant v Bristol-Myers Squibb, 97 F Supp 2d 986, 992 [2000]). [read post]
15 Jan 2009, 3:35 am
Just to recap then, the High Court of Delhi recently granted an ex parte restraining order in favour of Bristol Myers Squibb restraining the defendants, Hetero Drugs (an Indian generic firm) from manufacturing, selling, distributing, advertising, exporting, offering for sale or in any manner dealing directly or indirectly in any product infringing the plaintiffs product patent covering Dasatinib, a drug used in the treatment of Chronic Myloeid Leukemia. [read post]
24 Jan 2013, 11:49 am
Bristol-Myers Squibb Co., No. 06-6050 (FLW) (D.N.J. [read post]
16 Oct 2024, 9:37 pm
” Citing to “[b]inding Circuit law” in Bristol-Myers Squibb v. [read post]
18 Jan 2017, 10:19 am
(relisted after the January 6 and January 13 conferences) Bristol-Myers Squibb Co. v. [read post]
15 May 2014, 11:40 am
I accept that, for the reasons explained by Jacob J in Bristol-Myers Squibb and Lord Hoffmann in Kirin-Amgen, courts should be cautious before relying upon prosecution history as an aid to construction. [read post]
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
28 Oct 2014, 3:14 pm
Bristol-Myers Squibb, Inc., 750 F.3d 111, 111 (1st Cir. 2014). [read post]
25 May 2021, 3:00 am
Generally, most of our analysis came from the multitude of court cases involving personal jurisdiction (e.g., International Shoe, Bristol-Myers Squibb, Daimler A.G., etc.). [read post]
3 Mar 2012, 5:36 pm
Bristol-Myers Squibb, 97 F. [read post]
